Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomlinson, C
Right arrow Articles by Wallace, A M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomlinson, C
Right arrow Articles by Wallace, A M
Archives of Disease in Childhood Fetal and Neonatal Edition 2004;89:F558-F559
© 2004 Archives of Disease in Childhood Fetal and Neonatal Edition


SHORT REPORT

Testosterone measurements in early infancy

C Tomlinson1, H Macintyre2, C A Dorrian2, S F Ahmed1, A M Wallace2

1 Bone & Endocrine Research Group, Department of Child Health, Royal Hospital For Sick Children, Yorkhill, Glasgow G3 8SJ, Scotland, UK
2 Department of Clinical Biochemistry, Glasgow Royal Infirmary, Glasgow G4 0SF

Correspondence to:
Correspondence to:
Dr Wallace
Department of Clinical Biochemistry, Glasgow Royal Infirmary, Glasgow G4 0SF, Scotland, UK; MWallace{at}gri-biochem.org.uk


ABSTRACT
Circulating testosterone concentrations in infants measured by a direct chemiluminescent immunoassay (Bayer ADVIA Centaur) were compared with those measured by a traditional radioimmunoassay using solvent extraction. The results confirm that neonatal circulating testosterone concentrations are method dependent, and each laboratory should establish method related reference ranges especially if using a direct commercial immunoassay. The results indicate that the Bayer ADVIA Centaur procedure can be used reliably in neonates. Expected values for male and female infants < 10 days old were 2.5–11.1 (n  =  36) and 1.7–5.6 (n  =  36) nmol/l respectively. For older neonates (10–50 days) the ranges were 0.2–17.2 (n  =  42) and 0.1–1.5 (n  = 7) nmol/l respectively.


Keywords: intersex; sex differentiation; sex steroids; testosterone; assay methods







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health